Accretion Pharmaceuticals
Accretion Pharmaceuticals Share Price Chart
Accretion Pharmaceuticals last traded at ₹190.00 (2026-10-13). Over the past month the stock moved -9.5%, three months the stock moved +59.1%, year the stock moved +223.7%. Its closing range over 52 weeks is ₹54.60 – ₹219.00, with the latest close 13.2% below the high.
Closing prices up to 2026-10-13.
About Accretion Pharmaceuticals
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.[1]
Business Profile[1] The company manufactures pharmaceutical formulations, including both generic and branded products. It offers contract and third-party manufacturing services for domestic and international markets. Its clientele includes private institutions, government sectors (state and central), and reputed pharmaceutical companies.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Accretion Pharmaceuticals reported sales of ₹45.89 crore (+243.7%) and net profit of ₹4.92 crore (+230.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 45.89 | 7.88 | 17.17 | 4.92 | 4.43 |
| Sep 2025 | 43.74 | 7.07 | 16.16 | 4.75 | 4.27 |
| Mar 2025 | 38.81 | 7.54 | 19.43 | 4.33 | 5.30 |
| Sep 2024 | 18.56 | 4.33 | 23.33 | 2.46 | 3.01 |
| Mar 2024 | 13.35 | 2.57 | 19.25 | 1.49 | 3.72 |
| Mar 2026 | |
|---|---|
| Sales growth | +243.7% |
| Operating profit growth | +206.6% |
| Net profit growth | +230.2% |
| EPS growth | +19.1% |
| OPM % | 17.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Accretion Pharmaceuticals reported sales of ₹89.63 crore (+56.2%) and net profit of ₹9.67 crore (+42.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 89.63 | 14.95 | 16.68 | 9.67 | 8.70 |
| Mar 2025 | 57.38 | 11.89 | 20.72 | 6.79 | 8.31 |
| Mar 2024 | 13.35 | 2.57 | 19.25 | 1.49 | 3.72 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +329.8% | +56.2% |
| Operating profit growth | +362.6% | +25.7% |
| Net profit growth | +355.7% | +42.4% |
| EPS growth | +123.4% | +4.7% |
| OPM % | 20.7% | 16.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Accretion Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Accretion Pharmaceuticals Submits Structured Digital Database Compliance Certificate for FY Ended 31st March, 2026 - scanx.trade
Frequently Asked Questions
What is Accretion Pharmaceuticals's current stock price?
Accretion Pharmaceuticals shares were last quoted at ₹190.00 (+0.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Accretion Pharmaceuticals?
Accretion Pharmaceuticals has a price-to-earnings (P/E) ratio of 23.37 and a price-to-book (P/B) ratio of 4.13. The industry P/E is 53.33.
What is the 52-week high and low of Accretion Pharmaceuticals?
The 52-week high of Accretion Pharmaceuticals is ₹219.00 and the 52-week low is ₹53.80.
What is the market cap of Accretion Pharmaceuticals?
The market capitalisation of Accretion Pharmaceuticals is about ₹225.99 crore.
How did Accretion Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Mar 2026), Accretion Pharmaceuticals reported sales of ₹45.89 crore (+243.7%) and net profit of ₹4.92 crore (+230.2%), compared with the same quarter last year.
Is Accretion Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Accretion Pharmaceuticals has a 3-year ROE of 35.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Accretion Pharmaceuticals?
Promoters hold about 73.52% of Accretion Pharmaceuticals.
Which sector does Accretion Pharmaceuticals belong to?
Accretion Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.